Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy for the Treatment of Helicobacter Pylori Infection in U.S. Adolescents: A Prospective Open-Label Study

NCT07860112 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT07860112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07860112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy for the Treatment of Helicobacter Pylori Infection in U.S. Adolescents: A Prospective Open-Label Study
Lead sponsor
Boston Children's Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection